Takeda Pharmaceutical
281 hedge funds and large institutions have $1.06B invested in Takeda Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 72 increasing their positions, 99 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
281
Holders Change
+6
Holders Change %
+2.18%
% of All Funds
4.53%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
54
Increased
72
Reduced
99
Closed
43
Calls
$39.2M
Puts
$16.1M
Net Calls
+$23.1M
Net Calls Change
+$3.82M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$43.4M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$41.7M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$38.5M |
| 4 |
Millennium Management
New York
|
+$19.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.59M |
